MARKET

SENS

SENS

SENSEONICS
AMEX

Real-time Quotes | Nasdaq Last Sale

3.570
-0.160
-4.29%
After Hours: 3.610 +0.04 +1.12% 19:59 09/24 EDT
OPEN
3.630
PREV CLOSE
3.730
HIGH
3.680
LOW
3.560
VOLUME
6.75M
TURNOVER
--
52 WEEK HIGH
5.56
52 WEEK LOW
0.3497
MARKET CAP
1.59B
P/E (TTM)
-2.2221
1D
5D
1M
3M
1Y
5Y
Demand for Disinfectant Products Continues to Grow Despite the Containment of the Pandemic
/PRNewswire/ -- The economy has shown signs of recovery, but fears related to the pandemic and its new variants remain. Last year, the World Health Organization (WHO) published a list of medical devices required, broken down into several categories includi...
PR Newswire - PRF · 5d ago
Particulate Matter Sensor Market- Global Size, Growth Insight, Share, Trends, Industry Key Players, Regional Forecast To 2029
Research Nester released a report titled ": Global Demand Analysis & Opportunity Outlook 2029"which delivers detailed overview of the global particulate matter sensor market in terms of market segmentation by type, end user and region.
AmericaNewsHour · 6d ago
Is Senseonics a Buy Under $4?
StockNews.com · 09/16 08:44
Senseonics' Glucose Monitoring System to be Offered to University Hospitals Accountable Care Organization's Medicare Members in Cleveland, Ohio
MT Newswires · 09/14 04:51
Senseonics Announces Collaboration With University Hospitals Accountable Care Organization In Cleveland, Ohio
Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with
Benzinga · 09/13 20:06
Senseonics Announces a Collaboration with the University Hospitals Accountable Care Organization (UHACO) in Cleveland, Ohio
GERMANTOWN, Md., September 13, 2021--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for ...
Business Wire · 09/13 20:05
Senseonics to Participate in the H.C. Wainwright Global Investment Conference
GERMANTOWN, Md., September 09, 2021--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabet...
Business Wire · 09/09 22:59
Senseonic Stock Is Climbing After Bouncing Back From a Disappointing Q2
Investor Place · 09/02 10:00
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SENS. Analyze the recent business situations of SENSEONICS through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SENS stock price target is 3.460 with a high estimate of 6.00 and a low estimate of 0.8000.
EPS
Institutional Holdings
Institutions: 117
Institutional Holdings: 93.52M
% Owned: 21.00%
Shares Outstanding: 445.25M
TypeInstitutionsShares
Increased
49
4.74M
New
13
3.28M
Decreased
18
5.37M
Sold Out
21
1.58M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.61%
Healthcare Equipment & Supplies
-0.42%
Key Executives
Chairman/Independent Director
Stephen DeFalco
President/Chief Executive Officer/Director
Timothy Goodnow
Chief Financial Officer/Treasurer/Secretary
Nick Tressler
Chief Operating Officer
Mukul Jain
Vice President/General Manager
Mirasol Panlilio
General Counsel
Kenneth Horton
Other/Director
Francine Kaufman
Director
John Marotta
Director
Robert Schumm
Independent Director
Steven Edelman
Independent Director
Edward Fiorentino
Independent Director
Douglas Prince
Independent Director
Anthony Raab
Independent Director
Douglas Roeder
No Data
About SENS
Senseonics Holdings, Inc. is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes. The Company's Eversense system consists of components, such as a sensor, which is inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user's mobile device, such as a smartphone, Apple Watch or tablet.

Webull offers kinds of Senseonics Holdings Inc stock information, including AMEX:SENS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SENS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SENS stock methods without spending real money on the virtual paper trading platform.